Functional consequences of natural sequence variation of murine cytomegalovirus m157 for Ly49 receptor specificity and NK cell activation

Journal of Immunology

Volumn 186, Issue 3, 2011, Pages 1713-1722

  Corbett, Alexandra J ^a   Coudert, Jerome D ^b   Forbes, Catherine A ^b   Scalzo, Anthony A ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; VIRAL CLEARANCE;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; EPITOPES; GENETIC VARIATION; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, 129 STRAIN; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NZB; MODELS, IMMUNOLOGICAL; MUROMEGALOVIRUS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; PROTEIN BINDING; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY;

EID: 79251589614     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003308     Document Type: Article

References (59)

1. Stewart, C. A., E. Vivier, and M. Colonna. 2006. Strategies of natural killer cell recognition and signaling. Curr. Top. Microbiol. Immunol. 298: 1-21.
2. Brown, M. G., A. O. Dokun, J. W. Heusel, H. R. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, and W. M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292: 934-937.
3. Daniels, K. A., G. Devora, W. C. Lai, C. L. O'Donnell, M. Bennett, and R. M. Welsh. 2001. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194: 29-44.
4. Lee, S. H., S. Girard, D. Macina, M. Busà, A. Zafer, A. Belouchi, P. Gros, and S. M. Vidal. 2001. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28: 42-45.
5. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
6. Smith, H. R., J. W. Heusel, I. K. Mehta, S. Kim, B. G. Dorner, O. V. Naidenko, K. Iizuka, H. Furukawa, D. L. Beckman, J. T. Pingel, et al. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99: 8826-8831.
7. Kane, K. P., K. J. Lavender, and B. J. Ma. 2004. Ly-49 receptors and their functions. Crit. Rev. Immunol. 24: 321-348.
8. Moretta, L., and A. Moretta. 2004. Killer immunoglobulin-like receptors. Curr. Opin. Immunol. 16: 626-633.
9. Smith, H. R., F. M. Karlhofer, and W. M. Yokoyama. 1994. Ly-49 multigene family expressed by IL-2-activated NK cells. J. Immunol. 153: 1068-1079.
10. Wilhelm, B. T., L. Gagnier, and D. L. Mager. 2002. Sequence analysis of the ly49 cluster in C57BL/6 mice: a rapidly evolving multigene family in the immune system. Genomics 80: 646-661.
11. Anderson, S. K., K. Dewar, M. L. Goulet, G. Leveque, and A. P. Makrigiannis. 2005. Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype. Genes Immun. 6: 481-492.
12. Proteau, M. F., E. Rousselle, and A. P. Makrigiannis. 2004. Mapping of the BALB/c Ly49 cluster defines a minimal natural killer cell receptor gene repertoire. Genomics 84: 669-677.
13. Makrigiannis, A. P., A. T. Pau, A. Saleh, R. Winkler-Pickett, J. R. Ortaldo, and S. K. Anderson. 2001. Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J. Immunol. 166: 5034-5043.
14. Makrigiannis, A. P., A. T. Pau, P. L. Schwartzberg, D. W. McVicar, T. W. Beck, and S. K. Anderson. 2002. A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice. Genomics 79: 437-444.
15. Belanger, S., L. H. Tai, S. K. Anderson, and A. P. Makrigiannis. 2008. Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome. Genes Immun. 9: 509-521.
16. Abi-Rached, L., and P. Parham. 2005. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J. Exp. Med. 201: 1319-1332.
17. Arase, H., and L. L. Lanier. 2004. Specific recognition of virus-infected cells by paired NK receptors. Rev. Med. Virol. 14: 83-93.
18. Adams, E. J., Z. S. Juo, R. T. Venook, M. J. Boulanger, H. Arase, L. L. Lanier, and K. C. Garcia. 2007. Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors. Proc. Natl. Acad. Sci. USA 104: 10128-10133.
19. Voigt, V., C. A. Forbes, J. N. Tonkin, M. A. Degli-Esposti, H. R. Smith, W. M. Yokoyama, and A. A. Scalzo. 2003. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc. Natl. Acad. Sci. USA 100: 13483-13488.
20. Booth, T.W., A. A. Scalzo, C. Carrello, P. A. Lyons, H. E. Farrell, G. R. Singleton, and G. R. Shellam. 1993.Molecular and biological characterization of new strains of murine cytomegalovirus isolated from wild mice. Arch. Virol. 132: 209-220.
21. George, T. C., L. H. Mason, J. R. Ortaldo, V. Kumar, and M. Bennett. 1999. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J. Immunol. 162: 2035-2043. (Pubitemid 29288822)
22. Ortaldo, J. R., R.Winkler-Pickett, J.Willette-Brown, R. L.Wange, S. K. Anderson, G. J. Palumbo, L. H. Mason, and D. W. McVicar. 1999. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors. J. Immunol. 163: 5269-5277.
23. Scalzo, A. A., M. G. Brown, D. T. Chu, J. W. Heusel, W. M. Yokoyama, and C. A. Forbes. 1999. Development of intra-natural killer complex (NKC) recombinant and congenic mouse strains for mapping and functional analysis of NK cell regulatory loci. Immunogenetics 49: 238-241.
24. Mehta, I. K., J. Wang, J. Roland, D. H. Margulies, and W. M. Yokoyama. 2001. Ly49A allelic variation and MHC class I specificity. Immunogenetics 53: 572-583.
25. Chalmer, J. E., J. S. Mackenzie, and N. F. Stanley. 1977. Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J. Gen. Virol. 37: 107-114.
26. Idris, A. H., K. Iizuka, H. R. Smith, A. A. Scalzo, and W. M. Yokoyama. 1998. Genetic control of natural killing and in vivo tumor elimination by the Chok locus. J. Exp. Med. 188: 2243-2256.
27. Frohman, M. A., M. K. Dush, and G. R. Martin. 1988. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA 85: 8998-9002.
28. Kitamura, T., Y. Koshino, F. Shibata, T. Oki, H. Nakajima, T. Nosaka, and H. Kumagai. 2003. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp. Hematol. 31: 1007-1014.
29. Tusnády, G. E., and I. Simon. 1998. Principles governing amino acid composition of integral membrane proteins: application to topology prediction. J. Mol. Biol. 283: 489-506.
30. Tusnády, G. E., and I. Simon. 2001. The HMMTOP transmembrane topology prediction server. Bioinformatics 17: 849-850.
31. Corbett, A. J., C. A. Forbes, D. Moro, and A. A. Scalzo. 2007. Extensive sequence variation exists among isolates of murine cytomegalovirus within members of the m02 family of genes. J. Gen. Virol. 88: 758-769.
32. Farrell, H. E., and G. R. Shellam. 1989. Immunoblot analysis of the antibody response to murine cytomegalovirus in genetically resistant and susceptible mice. J. Gen. Virol. 70: 2573-2586.
33. Xu, J., P. A. Lyons, M. D. Carter, T. W. Booth, N. J. Davis-Poynter, G. R. Shellam, and A. A. Scalzo. 1996. Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus. J. Gen. Virol. 77: 49-59.
34. Warming, S., N. Costantino, D. L. Court, N. A. Jenkins, and N. G. Copeland. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33: e36.
35. Redwood, A. J., M. Messerle, N. L. Harvey, C. M. Hardy, U. H. Koszinowski, M. A. Lawson, and G. R. Shellam. 2005. Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception. J. Virol. 79: 2998-3008.
36. van Dommelen, S. L., N. Sumaria, R. D. Schreiber, A. A. Scalzo, M. J. Smyth, and M. A. Degli-Esposti. 2006. Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity 25: 835-848.
37. Brunner, K. T., J. Mauel, J. C. Cerottini, and B. Chapuis. 1968. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14: 181-196.
38. Brown, M. G., A. A. Scalzo, L. R. Stone, P. Y. Clark, Y. Du, B. Palanca, and W. M. Yokoyama. 2001. Natural killer gene complex (Nkc) allelic variability in inbred mice: evidence for Nkc haplotypes. Immunogenetics 53: 584-591.
39. Lee, S. H., J. Gitas, A. Zafer, P. Lepage, T. J. Hudson, A. Belouchi, and S. M. Vidal. 2001. Haplotype mapping indicates two independent origins for the Cmv1s susceptibility allele to cytomegalovirus infection and refines its localization within the Ly49 cluster. Immunogenetics 53: 501-505.
40. Corral, L., H. Takizawa, T. Hanke, A. M. Jamieson, and D. H. Raulet. 1999. A new monoclonal antibody reactive with several Ly49 NK cell receptors mediates redirected lysis of target cells. Hybridoma 18: 359-366.
41. Sjölin, H., E. Tomasello, M. Mousavi-Jazi, A. Bartolazzi, K. Kärre, E. Vivier, and C. Cerboni. 2002. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J. Exp. Med. 195: 825-834.
42. Rodriguez, M., P. Sabastian, P. Clark, and M. G. Brown. 2004. Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand White mice. J. Immunol. 173: 6312-6318.
43. Scalzo, A. A., P. A. Lyons, N. A. Fitzgerald, C. A. Forbes, W. M. Yokoyama, and G. R. Shellam. 1995. Genetic mapping of Cmv1 in the region of mouse chromosome 6 encoding the NK gene complex-associated loci Ly49 and musNKR-P1. Genomics 27: 435-441.
44. Scalzo, A. A., M. Manzur, C. A. Forbes, M. G. Brown, and G. R. Shellam. 2005. NK gene complex haplotype variability and host resistance alleles to murine cytomegalovirus in wild mouse populations. Immunol. Cell Biol. 83: 144-149.
45. Makrigiannis, A. P., and S. K. Anderson. 2000. Ly49 gene expression in different inbred mouse strains. Immunol. Res. 21: 39-47.
46. Bubić, I., M. Wagner, A. Krmpotić, T. Saulig, S. Kim, W. M. Yokoyama, S. Jonjić, and U. H. Koszinowski. 2004. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J. Virol. 78: 7536-7544.
47. Regunathan, J., Y. Chen, D. Wang, and S. Malarkannan. 2005. NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors. Blood 105: 233-240. (Pubitemid 40053088)
48. Coudert, J. D., and W. Held. 2006. The role of the NKG2D receptor for tumor immunity. Semin. Cancer Biol. 16: 333-343.
49. Coudert, J. D., L. Scarpellino, F. Gros, E. Vivier, and W. Held. 2008. Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways. Blood 111: 3571-3578.
50. Orr, M. T., J. C. Sun, D. G. Hesslein, H. Arase, J. H. Phillips, T. Takai, and L. L. Lanier. 2009. Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection. J. Exp. Med. 206: 807-817.
51. Orr, M. T., W. J. Murphy, and L. L. Lanier. 2010. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat. Immunol. 11: 321-327.
52. Babic, M., M. Pyzik, B. Zafirova, M. Mitrovic, V. Butorac, L. L. Lanier, A. Krmpotic, S. M. Vidal, and S. Jonjic. 2010. Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognition in natural killer cell dependent virus control in vivo. J. Exp. Med. 207: 2663-2673.
53. Desrosiers, M. P., A. Kielczewska, J. C. Loredo-Osti, S. G. Adam, A. P. Makrigiannis, S. Lemieux, T. Pham, M. B. Lodoen, K. Morgan, L. L. Lanier, and S. M. Vidal. 2005. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat. Genet. 37: 593-599.
54. k role in NK cell-mediated resistance in acute murine cytomegalovirus-infected MA/My mice. J. Immunol. 175: 6820-6828.
55. k class I proteins. J. Virol. 81: 229-236.
56. Kielczewska, A., M. Pyzik, T. Sun, A. Krmpotic, M. B. Lodoen, M. W. Munks, M. Babic, A. B. Hill, U. H. Koszinowski, S. Jonjic, et al. 2009. Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J. Exp. Med. 206: 515-523.
57. Smith, L. M., A. R. McWhorter, L. L. Masters, G. R. Shellam, and A. J. Redwood. 2008. Laboratory strains of murine cytomegalovirus are genetically similar to but phenotypically distinct from wild strains of virus. J. Virol. 82: 6689-6696.
58. Cerboni, C., A. Achour, A. Wärnmark, M. Mousavi-Jazi, T. Sandalova, M. L. Hsu, D. Cosman, K. Kärre, and E. Carbone. 2006. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j. Eur. J. Immunol. 36: 732-741.
59. Andrews, D. M., M. J. Estcourt, C. E. Andoniou, M. E. Wikstrom, A. Khong, V. Voigt, P. Fleming, H. Tabarias, G. R. Hill, R. G. van der Most, et al. 2010. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J. Exp. Med. 207: 1333-1343.